Companies: 10,795·Total market cap: $144.5T
Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILDNASDAQHealthcare● Active
$129.16
$-0.02(-0.02%)
Market Cap$160.4B
P/E Ratio
52W High$157.29
52W Low$104.46

Gilead Sciences, Inc.(GILD)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GILD · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$29.44B$28.75B$27.12B$27.28B$27.30B
Cost of Revenue$6.23B$6.25B$6.50B$5.66B$6.60B
Gross Profit$23.21B$22.50B$20.62B$21.62B$20.70B
Gross Margin %(computed)78.83%78.26%76.04%79.26%75.82%
Operating Expenses
R&D Expenses$5.80B$5.91B$5.72B$4.98B$4.60B
G&A Expenses$2.19B$2.64B$2.82B$4.89B$4.51B
Total Operating Expenses$11.51B$20.84B$13.01B$14.29B$10.79B
Operating Income$11.70B$1.66B$7.61B$7.33B$9.92B
Operating Margin %(computed)39.74%5.78%28.05%26.87%36.32%
Interest Income$0.35B$0.28B$0.38B$0.11B$0.00B
Interest Expense$1.02B$0.98B$0.94B$0.94B$1.00B
Income Before Tax$9.80B$0.69B$6.86B$5.81B$8.28B
Income Tax Expense$1.29B$0.21B$1.25B$1.25B$2.08B
Net Income$8.51B$0.48B$5.67B$4.59B$6.22B
Net Margin %(computed)28.90%1.67%20.89%16.83%22.80%
Per Share & EBITDA
EPS (Basic)$6.84$0.38$4.54$3.66$4.96
Wtd Avg Shares1.24B1.25B1.25B1.25B1.26B
EBITDA$13.58B$4.43B$10.50B$8.85B$11.33B
EBITDA Margin %(computed)46.12%15.42%38.71%32.45%41.49%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Gilead Sciences, Inc.

关于Gilead Sciences, Inc.(GILD)损益表

Gilead Sciences, Inc.(GILD)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GILD实现营收$29.44B,毛利润$23.21B(毛利率78.83%),净利润$8.51B(净利率28.90%)。

常见问题

GILD · 4 问

Gilead Sciences, Inc.(GILD)2025财年营收为$29.44B,同比up2.4%。

GILD revenueGILD salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08